Lometrics
Lometrics is developing a breath-based diagnostic platform that detects volatile organic compounds in exhaled breath to provide objective signals of brain injury and recovery. The technology aims to replace subjective symptom checklists and balance tests with quantitative, point-of-care measurements suitable for sports sidelines, military settings, and pediatric clinics. The company is currently in the research stage and seeking pilot partners and collaborators.
- Healthcare Technology
- Medical Devices
- Biotechnology
- Sports Technology
- Hardware
- Data & Analytics
- Artificial Intelligence
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Brain injury assessment relies heavily on subjective symptom checklists, balance tests, and patient self-reporting, which depend on accurate self-description and clinician interpretation. There is no objective point-of-care test that can scalably measure acute brain injury without depending on the presence of particular symptoms. This leads to athletes cleared too early, missed injuries, and unmonitored recovery, with return-to-play and return-to-duty decisions being either conservative guesses or dangerous gambles.
Solution
Lometrics is developing a breath-based approach that analyzes exhaled breath to detect volatile organic compounds—biochemical signals that reflect metabolic changes in the brain following injury. By sampling breath over time, the company aims to generate objective, quantitative insight into concussion status and recovery trajectories. This approach provides a standardized measurement that does not depend on patient self-report or symptom presence, making it suitable for populations who struggle to describe symptoms accurately, such as pediatric patients. The goal is to deliver objective signals of brain recovery directly to athletic trainers, medics, and physicians at the point of care, enabling fast, data-informed decisions about return-to-play and return-to-duty timelines.
Target Audience
Primary customers include sports teams and leagues, military and defense programs, pediatric concussion clinics, and clinical research institutions seeking standardized, objective brain injury assessment tools.
Features
- Breath-based detection of volatile organic compounds as biomarkers for brain injury and recovery
- Non-invasive sample collection that eliminates dependence on patient self-report or symptom checklists
- Longitudinal analysis capability to track recovery patterns over time and generate progression insights
- Designed for austere and high-stakes environments including sports sidelines and military field settings
- Standardized quantitative data collection suitable for clinical research and longitudinal concussion studies
- Point-of-care delivery model intended for athletic trainers, medics, and physicians without specialized laboratory equipment